This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Santa Clara, CA-based Agilent Technologies, Inc. was originally a spin-off from Hewlett-Packard. The company is an original equipment manufacturer (OEM) of a broad-based portfolio of test and measurement products serving multiple end markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG). The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers’ representatives, telesales and electronic commerce.
Cognex Corporation (CGNX) Matches Q4 Earnings Estimates
by Zacks Equity Research
Cognex Corporation (CGNX) delivered earnings and revenue surprises of 0% and 4.27%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Agilent Technologies (A) Surpasses Market Returns: Some Facts Worth Knowing
by Zacks Equity Research
Agilent Technologies (A) reachead $132.24 at the closing of the latest trading day, reflecting a +1.91% change compared to its last close.
Agilent Technologies (A) Outperforms Broader Market: What You Need to Know
by Zacks Equity Research
In the most recent trading session, Agilent Technologies (A) closed at $134.07, indicating a +0.96% shift from the previous trading day.
Agilent Technologies (A) Stock Slides as Market Rises: Facts to Know Before You Trade
by Zacks Equity Research
Agilent Technologies (A) concluded the recent trading session at $132.97, signifying a -0.06% move from its prior day's close.
FTV vs. A: Which Stock Is the Better Value Option?
by Zacks Equity Research
FTV vs. A: Which Stock Is the Better Value Option?
Fortive (FTV) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Fortive (FTV) delivered earnings and revenue surprises of 5.38% and 0.99%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Agilent Technologies (A) Advances While Market Declines: Some Information for Investors
by Zacks Equity Research
In the latest trading session, Agilent Technologies (A) closed at $130.99, marking a +0.85% move from the previous day.
The Zacks Analyst Blog Highlights Oracle, Progressive, MercadoLibre, Moderna and Agilent
by Zacks Equity Research
Oracle, Progressive, MercadoLibre, Moderna and Agilent are included in this Analyst Blog.
Top Stock Reports for Oracle, Progressive & MercadoLibre
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Oracle Corporation (ORCL), The Progressive Corporation (PGR) and MercadoLibre, Inc. (MELI).
Agilent (A) Boosts DGG Segment With ProteoAnalyzer System
by Zacks Equity Research
Agilent (A) bolsters protein analysis capabilities with the ProteoAnalyzer system.
FTV vs. A: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
FTV vs. A: Which Stock Is the Better Value Option?
Why Is Agilent (A) Up 12.8% Since Last Earnings Report?
by Zacks Equity Research
Agilent (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Agilent (A) Enhances BioTek Cytation C10 With New Technology
by Zacks Equity Research
Agilent (A) adds a water immersion and confocal spinning disk technology to BioTek Cytation C10, enhancing image quality and reducing harmful effects on live-cell samples.
The Zacks Analyst Blog Highlights Visa, Marriott International, Parker-Hannifin, FedEx and Agilent Technologies
by Zacks Equity Research
Visa, Marriott International, Parker-Hannifin, FedEx and Agilent Technologies are part of the Zacks top Analyst Blog.
Top Research Reports for Visa, Marriott International & Parker-Hannifin
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Visa Inc. (V), Marriott International, Inc. (MAR) and Parker-Hannifin Corporation (PH).
Agilent (A) Q4 Earnings & Revenues Beat Estimates, Down Y/Y
by Zacks Equity Research
Agilent's (A) fourth-quarter fiscal 2023 results are hurt by weakness in the LSAG segment and softness in the China market.
Agilent (A) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for Agilent (A) give a sense of how its business performed in the quarter ended October 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
A November to Remember As The Rally Continues on a Goldilocks Market Scenario
by Mayur Thaker
soft landing is now the base case, but how likely is it?
What to Note Ahead of Agilent Technologies' (A) Q4 Earnings
by Zacks Equity Research
Agilent's (A) results for the fiscal fourth quarter are expected to reflect strength across the ACG amid weakness in the LSAG segment.
Agilent (A) Boosts DGG Offerings With PD-L1 IHC 22C3 Approval
by Zacks Equity Research
Agilent (A) receives FDA approval for its PD-L1 IHC 22C3 diagnostic tool, benefiting PD1/PDL1 cancer patients.
Agilent Technologies (A) Beats Stock Market Upswing: What Investors Need to Know
by Zacks Equity Research
In the closing of the recent trading day, Agilent Technologies (A) stood at $113.60, denoting a +1.78% change from the preceding trading day.
Analysts Estimate Agilent Technologies (A) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Agilent (A) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Agilent Technologies (A) Stock Dips While Market Gains: Key Facts
by Zacks Equity Research
Agilent Technologies (A) reachead $109.39 at the closing of the latest trading day, reflecting a -1.04% change compared to its last close.
Agilent Technologies (A) Stock Dips While Market Gains: Key Facts
by Zacks Equity Research
In the closing of the recent trading day, Agilent Technologies (A) stood at $102.86, denoting a -0.49% change from the preceding trading day.
Ametek (AME) Q3 Earnings Surpass Estimates
by Zacks Equity Research
Ametek (AME) delivered earnings and revenue surprises of 3.80% and 1.55%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?